All In Biotech

Drug Trial Radar · NCT06608459

PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study

Open-Label, Single Arm Study of PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study

Last checked: Nov 20, 2026Latest source record: Oct 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Dec 2024

Primary completion

Dec 2026

Study completion Jun 2027

Sponsor

Lead sponsor
Filament Health Corp.Industry
Sponsor type
Industry
Collaborators
University of British Columbia
First posted
Sep 23, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 25 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if it is feasible to use PEX010 for the treatment of opioid use disorder in adults. The study will also assess the safety of PEX010. The main questions it aims to answer are: Can we successfully recruit participants, provide the drug and retain participants for the duration of the study? What medical problems do participants experience when taking PEX010? Participants will: Take PEX010 twice during the study Engage in cognitive behavioural therapy Visit the clinic once or twice per week for study intervention and followup visits

Conditions

  • Opioid Use Disorder

Interventions

  • PEX010-Assisted TherapyDrug

    The investigational medicinal product PEX010 is a capsule for oral administration that contains the drug substance PYEX.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of AEs and SAEsTime frame: 8 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.